- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 16, 2026 | 200.37M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 194.14M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 187.07M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $233K |
| Capex | Q1 2026 · Mar 31, 2025 | $112K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$3.05M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$844K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $27.85M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $19.96M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $67.55M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $64.22M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $107.38M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $100.8M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $154.62M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $156.89M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $175.34M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $174.38M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $222.91M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $221.86M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.01 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.04 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $19.95M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $20.29M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.64M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$7.72M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$354K |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.85M |
| Revenue | Q1 2026 · Mar 31, 2026 | $53.66M |
| Revenue | Q1 2026 · Mar 31, 2025 | $43.24M |